September 8th, 2010
New Therapy for a Rare Syndrome
Larry Husten, PHD
A team of French and Belgian investigators have found a promising new treatment for a rare inherited disorder that often leads to vascular dissection or rupture. In a report published online in the Lancet, Kim-Thanh Ong and colleagues compared the effect of celiprolol, a beta-blocker with beta-2 agonist properties, with placebo in 53 patients with […]
NEJM Journal Watch — Recent Cardiology Articles- Optimal Management of NSTEMI in Older Adults: A Meta-Analysis
- Which Cardiovascular Risk Calculator Is Best in Older Adults?
- A New Indication for Finerenone, a Mineralocorticoid-Receptor Antagonist
- Should Patients Take Once-Daily Antihypertensive Drugs in the Morning or the Evening?
- Exercise as Medicine for Preventing Colon Cancer Recurrence